CTMX

UNKNOWN

CytomX Therapeutics, Inc.

CIK: 0001501989

Strong Sell (50% confidence)

Last activity: 2 weeks ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Insider	Sells	Net Value	Holdings
McCarthy Sean A. CEO	1	-$764K	1,078,922 shares $6.93M
BELVIN MARCIA SVP, Chief Scientific Officer	1	-$202K	300,760 shares $1.93M
Chu Yu-Waye Chief Medical Officer	1	-$137K	189,446 shares $1.22M
Ogden Christopher Chief Financial Officer	1	-$124K	296,948 shares $1.91M

SELL McCarthy Sean A. (CEO)

118,969 shares @ $6.42

$764K

Mar 17, 2026

Conviction: | View SEC Filing →

SELL BELVIN MARCIA (SVP, Chief Scientific Officer)

31,492 shares @ $6.42

$202K

Mar 17, 2026

Conviction: | View SEC Filing →

SELL Chu Yu-Waye (Chief Medical Officer)

21,279 shares @ $6.42

$137K

Mar 17, 2026

Conviction: | View SEC Filing →

SELL Ogden Christopher (Chief Financial Officer)

19,323 shares @ $6.42

$124K

Mar 17, 2026

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.